フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Immupharma PLC 18 May 2023 18 May 2023 ImmuPharma PLC ("ImmuPharma" or the "Company") Positive guidance from the FDA Pre-IND...
London-based drug discovery and development company - Posts no revenue for 2022, compared to GBP118,350 for 2021. Pret ...
Immupharma PLC 11 May 2023 RNS: RELEASE ImmuPharma PLC ("ImmuPharma" or the "Company") FINAL RESULTS ANNOUNCEMENT for the year...
Immupharma PLC 10 May 2023 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant...
London-based drug discovery and development company - Notes the US Food & Drug Administration has set a date of June 7 ...
Immupharma PLC 19 April 2023 19(th) April 2023 ImmuPharma PLC ("ImmuPharma" or the "Company") FDA confirms Type-C meeting date...
London-based drug discovery and development company - Gets confirmation of a pre-investigational new drug meeting with ...
Immupharma PLC 12 April 2023 12 April 2023 ImmuPharma PLC ("ImmuPharma" or the "Company") ImmuPharma receives confirmation of...
ImmuPharma PLC on Monday said it submitted a phase 2/3 clinical trial protocol to the US Food & Drug Administration t ...
Immupharma PLC 27 March 2023 27 March 2023 ImmuPharma PLC ("ImmuPharma" or the "Company") Avion submits clinical protocol of...
Immupharma PLC 09 March 2023 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call...
ImmuPharma PLC on Monday said it has signed an initial collaboration agreement with Orano SA for its peptide technolo ...
Immupharma PLC 06 March 2023 6th March 2023 ImmuPharma PLC ("ImmuPharma" or the "Company") Collaboration with Orano on...
ImmuPharma PLC on Monday confirmed alongside its partner Avion Pharmaceuticals that a phase 2/3 adaptive trial will b ...
Immupharma PLC 06 February 2023 6 February 2023 ImmuPharma PLC ("ImmuPharma" or the "Company") Lupuzor(TM) Update Phase 2/3...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約